D.E. Shaw & Co Portfolio holdings
D. E. Shaw & Co., L.P., founded in 1988 by David E. Shaw, a former Columbia University computer science professor, is a New York City-based global investment management firm renowned for pioneering quantitative investing, managing over $70 billion in assets as of late 2024. Starting with $28 million from Paloma Partners and private investors, the firm employs sophisticated mathematical models and proprietary algorithms—initially developed by a team of scientists and programmers—to exploit market anomalies across public and private markets, including equities, fixed income, and alternatives. Headquartered above a Greenwich Village bookstore in its early days, it now boasts over 2,500 employees across offices in North America, Europe, and Asia, led by a seven-member Executive Committee since Shaw stepped back in 2001 to focus on D. E. Shaw Research. Despite setbacks like the 1998 Russia debt crisis and the 2008 financial downturn, the firm has maintained a reputation for analytical rigor, risk management, and innovation, balancing its computational roots with discretionary strategies.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
GE Vernova
GEV
|
+$686M |
| 2 |
Walt Disney
DIS
|
+$555M |
| 3 |
Palantir
PLTR
|
+$522M |
| 4 |
State Street Financial Select Sector SPDR ETF
XLF
|
+$493M |
| 5 |
TSMC
TSM
|
+$464M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Boeing
BA
|
+$981M |
| 2 |
iShares Core S&P 500 ETF
IVV
|
+$951M |
| 3 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$596M |
| 4 |
Eli Lilly
LLY
|
+$555M |
| 5 |
Arthur J. Gallagher & Co
AJG
|
+$499M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 15.18% |
| 2 | Healthcare | 9.91% |
| 3 | Consumer Discretionary | 9.25% |
| 4 | Financials | 6.44% |
| 5 | Industrials | 5.79% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2676
Rentokil
RTO
$12.3B
| $1.54M | ﹤0.01% |
+67,089
| New | +$1.62M |
|
2677
Bioventus
BVS
$947M
| $1.53M | ﹤0.01% |
167,751
+7,095
| +4% | +$70.9K |
|
2678
Matthews International
MATW
$863M
| $1.53M | ﹤0.01% |
68,738
-35,556
| -34% | -$925K |
|
2679
PUT
Dynatrace
DT
$14.2B
| $1.53M | ﹤0.01% |
32,400
-10,400
| -24% | -$569K |
|
2680
Design Therapeutics
DSGN
$862M
| $1.53M | ﹤0.01% |
395,251
-117,079
| -23% | -$559K |
|
2681
PUT
Ryder
R
$10.1B
| $1.52M | ﹤0.01% |
10,600
-15,400
| -59% | -$2.4M |
|
2682
Franklin Covey
FC
$242M
| $1.52M | ﹤0.01% |
55,166
+15,340
| +39% | +$508K |
|
2683
908 Devices
MASS
$341M
| $1.52M | ﹤0.01% |
339,715
+253,855
| +296% | +$752K |
|
2684
Qiagen
QGEN
$8.61B
| $1.52M | ﹤0.01% |
37,861
-203,377
| -84% | -$8.56M |
|
|
LOGC
2685
DELISTED
ContextLogic
LOGC
| $1.51M | ﹤0.01% |
216,931
+17,111
| +9% | +$127K |
|
|
CHAR
2686
Charlton Aria Acquisition Corp
CHAR
$116M
| $1.51M | ﹤0.01% |
150,000
| – | – |
|
2687
CALL
Emerson Electric
EMR
$87.5B
| $1.51M | ﹤0.01% |
+13,800
| New | +$1.66M |
|
2688
CALL
ServiceNow
NOW
$121B
| $1.51M | ﹤0.01% |
9,500
-60,500
| -86% | -$11.7M |
|
2689
PUT
Teva Pharmaceuticals
TEVA
$40.6B
| $1.51M | ﹤0.01% |
98,300
-41,200
| -30% | -$736K |
|
2690
PUT
Jefferies Financial Group
JEF
$13B
| $1.51M | ﹤0.01% |
28,200
-10,700
| -28% | -$726K |
|
2691
Stantec
STN
$8.34B
| $1.51M | ﹤0.01% |
18,200
+7,400
| +69% | +$592K |
|
|
EMBJ
2692
Embraer S.A. ADS
EMBJ
$12.8B
| $1.5M | ﹤0.01% |
+32,567
| New | +$1.45M |
|
2693
Cousins Properties
CUZ
$4.91B
| $1.5M | ﹤0.01% |
51,003
+1,831
| +4% | +$54.8K |
|
|
GSHRU
2694
Gesher Acquisition Corp II Units
GSHRU
| $1.5M | ﹤0.01% |
+150,000
| New | +$1.5M |
|
2695
CALL
Hilton Worldwide
HLT
$72.5B
| $1.5M | ﹤0.01% |
6,600
-20,500
| -76% | -$5.11M |
|
2696
MillerKnoll
MLKN
$1.61B
| $1.5M | ﹤0.01% |
+78,351
| New | +$1.67M |
|
|
GOOD
2697
Gladstone Commercial Corp
GOOD
$625M
| $1.5M | ﹤0.01% |
+99,870
| New | +$1.57M |
|
2698
CALL
Plug Power
PLUG
$2.89B
| $1.5M | ﹤0.01% |
1,108,000
-521,100
| -32% | -$991K |
|
2699
PUT
Steven Madden
SHOO
$3.53B
| $1.49M | ﹤0.01% |
+56,100
| New | +$1.97M |
|
2700
Northeast Bank
NBN
$1.14B
| $1.49M | ﹤0.01% |
16,326
+2,394
| +17% | +$234K |
|
Similar funds
D.E. Shaw & Co's Q1 2025 Portfolio in Review
As of Q1 2025, D.E. Shaw & Co held 4,902 positions worth $112B, down 18% from $136B the previous quarter. Its ten largest holdings account for 11% of the portfolio.
D.E. Shaw & Co withdrew a net $21.6B in Q1 2025, closing 704 positions and reducing 1,734 holdings. Its most notable exit was iShares Core S&P 500 ETF, an estimated $951M position sold in full.
By sector, the portfolio is most concentrated in Technology at 15% of assets, up from 14% a quarter earlier, followed by Healthcare and Consumer Discretionary.
Against the trend, D.E. Shaw & Co opened a new position in KKR & Co 6.25% Series D Preferred Stock worth $88.2M.
- D.E. Shaw & Co's largest Q1 2025 buy was KKR & Co 6.25% Series D Preferred Stock: 1,800,000 shares worth $88.2M.
- D.E. Shaw & Co added most to GE Vernova in Q1 2025, an estimated $686M increase.
- D.E. Shaw & Co's biggest Q1 2025 reduction was Boeing, cutting an estimated $981M.
- D.E. Shaw & Co fully exited iShares Core S&P 500 ETF in Q1 2025, selling an estimated $951M.
- D.E. Shaw & Co's ten largest holdings make up 11% of its $112B portfolio in Q1 2025.
- D.E. Shaw & Co opened 569 new positions and closed 704 in Q1 2025.
- D.E. Shaw & Co's portfolio value fell 18% quarter-over-quarter to $112B.
Based on D.E. Shaw & Co's 13F filing for Q1 2025, filed 15 May 2025.